One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-112067
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 13 |
Affiliation: Dana-Farber Cancer Institute, University Hospital Cologne, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Humanitas University, University of Bologna, Los Angeles Medical Center, Churchill Hospital, Karmanos Cancer Institute, Emory University, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Princess Margaret Cancer Centre, University of Toronto, General University Hospital in Prague, Bristol-Myers Squibb (United States), Mayo ClinicNivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
